Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D. Merker, Nicholas C. Turner, Geoffrey R. Oxnard et al.|Journal of Clinical Oncology|2018Cited by 925
Integrating genomic features for non-invasive early lung cancer detectionJacob J. Chabon, Maximilian Diehn, Emily G. Hamilton et al.|Nature|2020Cited by 689
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patientsJacob J. Chabon, Maximilian Diehn|Nature Communications|2016Cited by 657
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, David R. Gandara, Philip C. Mack et al.|Journal of Thoracic Oncology|2021Cited by 642
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung CancerBailiang Li, Ruijiang Li, Yi Cui et al.|JAMA Oncology|2017Cited by 600